Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Nov;85(11):1771–1780. doi: 10.1054/bjoc.2001.2181

Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells

K Maaser 1, M Höpfner 1, A Jansen 1, G Weisinger 2, M Gavish 3, A P Kozikowski 4, A Weizman 5, P Carayon 6, E-O Riecken 1, M Zeitz 1, H Scherübl 1
PMCID: PMC2363981  PMID: 11742501

Abstract

The peripheral benzodiazepine receptor (PBR) has been implicated in growth control of various tumour models. Although colorectal cancers were found to overexpress PBR, the functional role of PBR in colorectal cancer growth has not been addressed to date. Using primary cell cultures of human colorectal cancers and the human colorectal carcinoma cell lines HT29, LS174T, and Colo320 DM we studied the involvement of PBR in the growth control and apoptosis of colorectal cancers. Both mRNA and protein expression of PBR were detected by RT-PCR and flow cytometry. Using confocal laser scanning microscopy and immunohistochemistry the PBR was localized in the mitochondria. The specific PBR ligands FGIN-1-27, PK 11195, or Ro5-4864 inhibited cell proliferation dose-dependently. FGIN-1-27 decreased the mitochondrial membrane potential, which indicates an early event in apoptosis. Furthermore, FGIN-1-27, PK 11195 or Ro5-4864 increased caspase-3 activity. In addition to their apoptosis-inducing effects, PBR ligands induced cell cycle arrest in the G 1/G 0-phase. Thus, our data demonstrate a functional involvement of PBR in colorectal cancer growth and qualify the PBR as a possible target for innovative therapeutic approaches in colorectal cancer. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: peripheral benzodiazepine receptor, colorectal cancer, cell proliferation, apoptosis, cell cycle

Full Text

The Full Text of this article is available as a PDF (205.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altschul S. F., Madden T. L., Schäffer A. A., Zhang J., Zhang Z., Miller W., Lipman D. J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997 Sep 1;25(17):3389–3402. doi: 10.1093/nar/25.17.3389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anholt R. R., Pedersen P. L., De Souza E. B., Snyder S. H. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem. 1986 Jan 15;261(2):576–583. [PubMed] [Google Scholar]
  3. Batra S., Iosif C. S. Elevated concentrations of mitochondrial peripheral benzodiazepine receptors in ovarian tumors. Int J Oncol. 1998 Jun;12(6):1295–1298. doi: 10.3892/ijo.12.6.1295. [DOI] [PubMed] [Google Scholar]
  4. Beinlich A., Strohmeier R., Kaufmann M., Kuhl H. Specific binding of benzodiazepines to human breast cancer cell lines. Life Sci. 1999;65(20):2099–2108. doi: 10.1016/s0024-3205(99)00475-0. [DOI] [PubMed] [Google Scholar]
  5. Beurdeley-Thomas A., Miccoli L., Oudard S., Dutrillaux B., Poupon M. F. The peripheral benzodiazepine receptors: a review. J Neurooncol. 2000;46(1):45–56. doi: 10.1023/a:1006456715525. [DOI] [PubMed] [Google Scholar]
  6. Bono F., Lamarche I., Prabonnaud V., Le Fur G., Herbert J. M. Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities. Biochem Biophys Res Commun. 1999 Nov 19;265(2):457–461. doi: 10.1006/bbrc.1999.1683. [DOI] [PubMed] [Google Scholar]
  7. Braestrup C., Squires R. F. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3805–3809. doi: 10.1073/pnas.74.9.3805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brown R. C., Degenhardt B., Kotoula M., Papadopoulous V. Location-dependent role of the human glioma cell peripheral-type benzodiazepine receptor in proliferation and steroid biosynthesis. Cancer Lett. 2000 Aug 11;156(2):125–132. doi: 10.1016/s0304-3835(00)00451-1. [DOI] [PubMed] [Google Scholar]
  9. Camins A., Diez-Fernandez C., Pujadas E., Camarasa J., Escubedo E. A new aspect of the antiproliferative action of peripheral-type benzodiazepine receptor ligands. Eur J Pharmacol. 1995 Jan 16;272(2-3):289–292. doi: 10.1016/0014-2999(94)00652-n. [DOI] [PubMed] [Google Scholar]
  10. Canat X., Guillaumont A., Bouaboula M., Poinot-Chazel C., Derocq J. M., Carayon P., LeFur G., Casellas P. Peripheral benzodiazepine receptor modulation with phagocyte differentiation. Biochem Pharmacol. 1993 Aug 3;46(3):551–554. doi: 10.1016/0006-2952(93)90535-5. [DOI] [PubMed] [Google Scholar]
  11. Cantor E. H., Kenessey A., Semenuk G., Spector S. Interaction of calcium channel blockers with non-neuronal benzodiazepine binding sites. Proc Natl Acad Sci U S A. 1984 Mar;81(5):1549–1552. doi: 10.1073/pnas.81.5.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Carmel I., Fares F. A., Leschiner S., Scherübl H., Weisinger G., Gavish M. Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line. Biochem Pharmacol. 1999 Jul 15;58(2):273–278. doi: 10.1016/s0006-2952(99)00093-3. [DOI] [PubMed] [Google Scholar]
  13. Cornu P., Benavides J., Scatton B., Hauw J. J., Philippon J. Increase in omega 3 (peripheral-type benzodiazepine) binding site densities in different types of human brain tumours. A quantitative autoradiography study. Acta Neurochir (Wien) 1992;119(1-4):146–152. doi: 10.1007/BF01541799. [DOI] [PubMed] [Google Scholar]
  14. Cossarizza A., Baccarani-Contri M., Kalashnikova G., Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun. 1993 Nov 30;197(1):40–45. doi: 10.1006/bbrc.1993.2438. [DOI] [PubMed] [Google Scholar]
  15. Dussossoy D., Carayon P., Feraut D., Belugou S., Combes T., Canat X., Vidal H., Casellas P. Development of a monoclonal antibody to immuno-cytochemical analysis of the cellular localization of the peripheral benzodiazepine receptor. Cytometry. 1996 May 1;24(1):39–48. doi: 10.1002/(SICI)1097-0320(19960501)24:1<39::AID-CYTO5>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  16. Fennell D. A., Corbo M., Pallaska A., Cotter F. E. Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamide PK11195 involves de novo generation of reactive oxygen species. Br J Cancer. 2001 May 18;84(10):1397–1404. doi: 10.1054/bjoc.2001.1788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fischer R., Schmitt M., Bode J. G., Häussinger D. Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells. Gastroenterology. 2001 Apr;120(5):1212–1226. doi: 10.1053/gast.2001.23260. [DOI] [PubMed] [Google Scholar]
  18. Garnier M., Boujrad N., Oke B. O., Brown A. S., Riond J., Ferrara P., Shoyab M., Suarez-Quian C. A., Papadopoulos V. Diazepam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheral-type benzodiazepine receptor and independent mechanisms. Endocrinology. 1993 Jan;132(1):444–458. doi: 10.1210/endo.132.1.8380386. [DOI] [PubMed] [Google Scholar]
  19. Gavish M., Bachman I., Shoukrun R., Katz Y., Veenman L., Weisinger G., Weizman A. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev. 1999 Dec;51(4):629–650. [PubMed] [Google Scholar]
  20. Gavish M., Katz Y., Bar-Ami S., Weizman R. Biochemical, physiological, and pathological aspects of the peripheral benzodiazepine receptor. J Neurochem. 1992 May;58(5):1589–1601. doi: 10.1111/j.1471-4159.1992.tb10030.x. [DOI] [PubMed] [Google Scholar]
  21. Gillies R. J., Didier N., Denton M. Determination of cell number in monolayer cultures. Anal Biochem. 1986 Nov 15;159(1):109–113. doi: 10.1016/0003-2697(86)90314-3. [DOI] [PubMed] [Google Scholar]
  22. Glassmeier G., Herzig K. H., Höpfner M., Lemmer K., Jansen A., Scherubl H. Expression of functional GABAA receptors in cholecystokinin-secreting gut neuroendocrine murine STC-1 cells. J Physiol. 1998 Aug 1;510(Pt 3):805–814. doi: 10.1111/j.1469-7793.1998.805bj.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Grabowski P., Mann B., Mansmann U., Lövin N., Foss H. D., Berger G., Scherübl H., Riecken E. O., Buhr H. J., Hanski C. Expression of SIALYL-Le(x) antigen defined by MAb AM-3 is an independent prognostic marker in colorectal carcinoma patients. Int J Cancer. 2000 Oct 15;88(2):281–286. [PubMed] [Google Scholar]
  24. Grabowski P., Schindler I., Anagnostopoulos I., Foss H. D., Riecken E. O., Mansmann U., Stein H., Berger G., Buhr H. J., Scherübl H. Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer. Eur J Gastroenterol Hepatol. 2001 Apr;13(4):405–411. doi: 10.1097/00042737-200104000-00018. [DOI] [PubMed] [Google Scholar]
  25. Hanski C., Itzkowitz S. H. Translating the knowledge of molecular alterations that occur during colon carcinogenesis into clinically relevant solutions. Ann N Y Acad Sci. 2000 Jun;910:1–9. [PubMed] [Google Scholar]
  26. Hardwick M., Fertikh D., Culty M., Li H., Vidic B., Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res. 1999 Feb 15;59(4):831–842. [PubMed] [Google Scholar]
  27. Hirsch J. D., Beyer C. F., Malkowitz L., Beer B., Blume A. J. Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. Mol Pharmacol. 1989 Jan;35(1):157–163. [PubMed] [Google Scholar]
  28. Hirsch T., Decaudin D., Susin S. A., Marchetti P., Larochette N., Resche-Rigon M., Kroemer G. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp Cell Res. 1998 Jun 15;241(2):426–434. doi: 10.1006/excr.1998.4084. [DOI] [PubMed] [Google Scholar]
  29. Höpfner M., Lemmer K., Jansen A., Hanski C., Riecken E. O., Gavish M., Mann B., Buhr H., Glassmeier G., Scherübl H. Expression of functional P2-purinergic receptors in primary cultures of human colorectal carcinoma cells. Biochem Biophys Res Commun. 1998 Oct 29;251(3):811–817. doi: 10.1006/bbrc.1998.9555. [DOI] [PubMed] [Google Scholar]
  30. Ikezaki K., Black K. L. Stimulation of cell growth and DNA synthesis by peripheral benzodiazepine. Cancer Lett. 1990 Feb;49(2):115–120. doi: 10.1016/0304-3835(90)90146-o. [DOI] [PubMed] [Google Scholar]
  31. Katz Y., Ben-Baruch G., Kloog Y., Menczer J., Gavish M. Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries. Clin Sci (Lond) 1990 Feb;78(2):155–158. doi: 10.1042/cs0780155. [DOI] [PubMed] [Google Scholar]
  32. Katz Y., Eitan A., Gavish M. Increase in peripheral benzodiazepine binding sites in colonic adenocarcinoma. Oncology. 1990;47(2):139–142. doi: 10.1159/000226806. [DOI] [PubMed] [Google Scholar]
  33. Kozikowski A. P., Ma D., Brewer J., Sun S., Costa E., Romeo E., Guidotti A. Chemistry, binding affinities, and behavioral properties of a new class of "antineophobic" mitochondrial DBI receptor complex (mDRC) ligands. J Med Chem. 1993 Oct 1;36(20):2908–2920. doi: 10.1021/jm00072a010. [DOI] [PubMed] [Google Scholar]
  34. Krueger K. E. Molecular and functional properties of mitochondrial benzodiazepine receptors. Biochim Biophys Acta. 1995 Dec 20;1241(3):453–470. doi: 10.1016/0304-4157(95)00016-x. [DOI] [PubMed] [Google Scholar]
  35. Kunert-Radek J., Stepień H., Pawlikowski M. Inhibition of rat pituitary tumor cell proliferation by benzodiazepines in vitro. Neuroendocrinology. 1994 Jan;59(1):92–96. doi: 10.1159/000126644. [DOI] [PubMed] [Google Scholar]
  36. Laird H. E., 2nd, Gerrish K. E., Duerson K. C., Putnam C. W., Russell D. H. Peripheral benzodiazepine binding sites in Nb 2 node lymphoma cells: effects on prolactin-stimulated proliferation and ornithine decarboxylase activity. Eur J Pharmacol. 1989 Nov 14;171(1):25–35. doi: 10.1016/0014-2999(89)90426-3. [DOI] [PubMed] [Google Scholar]
  37. Landau M., Weizman A., Zoref-Shani E., Beery E., Wasseman L., Landau O., Gavish M., Brenner S., Nordenberg J. Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cells. Biochem Pharmacol. 1998 Oct 15;56(8):1029–1034. doi: 10.1016/s0006-2952(98)00149-x. [DOI] [PubMed] [Google Scholar]
  38. Larochette N., Decaudin D., Jacotot E., Brenner C., Marzo I., Susin S. A., Zamzami N., Xie Z., Reed J., Kroemer G. Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp Cell Res. 1999 Jun 15;249(2):413–421. doi: 10.1006/excr.1999.4519. [DOI] [PubMed] [Google Scholar]
  39. Le Fur G., Perrier M. L., Vaucher N., Imbault F., Flamier A., Benavides J., Uzan A., Renault C., Dubroeucq M. C., Guérémy C. Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies. Life Sci. 1983 Apr 18;32(16):1839–1847. doi: 10.1016/0024-3205(83)90062-0. [DOI] [PubMed] [Google Scholar]
  40. Lemasters J. J., Nieminen A. L., Qian T., Trost L. C., Elmore S. P., Nishimura Y., Crowe R. A., Cascio W. E., Bradham C. A., Brenner D. A. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta. 1998 Aug 10;1366(1-2):177–196. doi: 10.1016/s0005-2728(98)00112-1. [DOI] [PubMed] [Google Scholar]
  41. Mancini M., Anderson B. O., Caldwell E., Sedghinasab M., Paty P. B., Hockenbery D. M. Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J Cell Biol. 1997 Jul 28;138(2):449–469. doi: 10.1083/jcb.138.2.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Marchetti P., Hirsch T., Zamzami N., Castedo M., Decaudin D., Susin S. A., Masse B., Kroemer G. Mitochondrial permeability transition triggers lymphocyte apoptosis. J Immunol. 1996 Dec 1;157(11):4830–4836. [PubMed] [Google Scholar]
  43. Marchetti P., Trincavelli L., Giannarelli R., Giusti L., Coppelli A., Martini C., Navalesi R., Lucacchini A. Characterization of peripheral benzodiazepine receptors in purified large mammal pancreatic islets. Biochem Pharmacol. 1996 Jun 14;51(11):1437–1442. doi: 10.1016/0006-2952(96)00082-2. [DOI] [PubMed] [Google Scholar]
  44. Neary J. T., Jorgensen S. L., Oracion A. M., Bruce J. H., Norenberg M. D. Inhibition of growth factor-induced DNA synthesis in astrocytes by ligands of peripheral-type benzodiazepine receptors. Brain Res. 1995 Mar 27;675(1-2):27–30. doi: 10.1016/0006-8993(95)00031-k. [DOI] [PubMed] [Google Scholar]
  45. Nicholson D. W., Ali A., Thornberry N. A., Vaillancourt J. P., Ding C. K., Gallant M., Gareau Y., Griffin P. R., Labelle M., Lazebnik Y. A. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995 Jul 6;376(6535):37–43. doi: 10.1038/376037a0. [DOI] [PubMed] [Google Scholar]
  46. Nuñez G., Benedict M. A., Hu Y., Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene. 1998 Dec 24;17(25):3237–3245. doi: 10.1038/sj.onc.1202581. [DOI] [PubMed] [Google Scholar]
  47. Papadopoulos V. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr Rev. 1993 Apr;14(2):222–240. doi: 10.1210/edrv-14-2-222. [DOI] [PubMed] [Google Scholar]
  48. Pawlikowski M., Kunert-Radek J., Radek A., Stepien H. Inhibition of cell proliferation of human gliomas by benzodiazepines in vitro. Acta Neurol Scand. 1988 Mar;77(3):231–233. doi: 10.1111/j.1600-0404.1988.tb05900.x. [DOI] [PubMed] [Google Scholar]
  49. Petit P. X., O'Connor J. E., Grunwald D., Brown S. C. Analysis of the membrane potential of rat- and mouse-liver mitochondria by flow cytometry and possible applications. Eur J Biochem. 1990 Dec 12;194(2):389–397. doi: 10.1111/j.1432-1033.1990.tb15632.x. [DOI] [PubMed] [Google Scholar]
  50. Ravagnan L., Marzo I., Costantini P., Susin S. A., Zamzami N., Petit P. X., Hirsch F., Goulbern M., Poupon M. F., Miccoli L. Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore. Oncogene. 1999 Apr 22;18(16):2537–2546. doi: 10.1038/sj.onc.1202625. [DOI] [PubMed] [Google Scholar]
  51. Stoebner P. E., Carayon P., Penarier G., Fréchin N., Barnéon G., Casellas P., Cano J. P., Meynadier J., Meunier L. The expression of peripheral benzodiazepine receptors in human skin: the relationship with epidermal cell differentiation. Br J Dermatol. 1999 Jun;140(6):1010–1016. doi: 10.1046/j.1365-2133.1999.02896.x. [DOI] [PubMed] [Google Scholar]
  52. Susin S. A., Zamzami N., Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta. 1998 Aug 10;1366(1-2):151–165. doi: 10.1016/s0005-2728(98)00110-8. [DOI] [PubMed] [Google Scholar]
  53. Taft W. C., DeLorenzo R. J. Micromolar-affinity benzodiazepine receptors regulate voltage-sensitive calcium channels in nerve terminal preparations. Proc Natl Acad Sci U S A. 1984 May;81(10):3118–3122. doi: 10.1073/pnas.81.10.3118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Tanimoto Y., Onishi Y., Sato Y., Kizaki H. Benzodiazepine receptor agonists modulate thymocyte apoptosis through reduction of the mitochondrial transmembrane potential. Jpn J Pharmacol. 1999 Feb;79(2):177–183. doi: 10.1254/jjp.79.177. [DOI] [PubMed] [Google Scholar]
  55. Venturini I., Zeneroli M. L., Corsi L., Avallone R., Farina F., Alho H., Baraldi C., Ferrarese C., Pecora N., Frigo M. Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma. Life Sci. 1998;63(14):1269–1280. doi: 10.1016/s0024-3205(98)00388-9. [DOI] [PubMed] [Google Scholar]
  56. Verma A., Snyder S. H. Peripheral type benzodiazepine receptors. Annu Rev Pharmacol Toxicol. 1989;29:307–322. doi: 10.1146/annurev.pa.29.040189.001515. [DOI] [PubMed] [Google Scholar]
  57. Vindeløv L., Christensen I. J. An integrated set of methods for routine flow cytometric DNA analysis. Methods Cell Biol. 1990;33:127–137. doi: 10.1016/s0091-679x(08)60519-1. [DOI] [PubMed] [Google Scholar]
  58. Wang J. K., Morgan J. I., Spector S. Benzodiazepines that bind at peripheral sites inhibit cell proliferation. Proc Natl Acad Sci U S A. 1984 Feb;81(3):753–756. doi: 10.1073/pnas.81.3.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Wang J. K., Taniguchi T., Spector S. Structural requirements for the binding of benzodiazepines to their peripheral-type sites. Mol Pharmacol. 1984 May;25(3):349–351. [PubMed] [Google Scholar]
  60. Xia W., Spector S., Hardy L., Zhao S., Saluk A., Alemane L., Spector N. L. Tumor selective G2/M cell cycle arrest and apoptosis of epithelial and hematological malignancies by BBL22, a benzazepine. Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7494–7499. doi: 10.1073/pnas.97.13.7494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S. A., Petit P. X., Mignotte B., Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med. 1995 Aug 1;182(2):367–377. doi: 10.1084/jem.182.2.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Zorov D. B. Mitochondrial damage as a source of diseases and aging: a strategy of how to fight these. Biochim Biophys Acta. 1996 Jul 18;1275(1-2):10–15. doi: 10.1016/0005-2728(96)00042-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES